|
David A. Gollnick has served as our Vice President of Research and Development and as a member of our Board since our inception in August 1998. From June 1996 to July 1998, Mr. Gollnick was Vice President of Research and Development at Coherent Medical Group. Mr. Gollnick holds a B.S. in Mechanical Engineering from Fresno State University.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained on Cutera's Investor Relations web pages which are not historical facts may be considered forward-looking statements, including, without limitation, statements as to trends, management's beliefs, expectations and opinions, which are based upon a number of assumptions concerning future conditions that ultimately may prove to be inaccurate. Such forward-looking statements are subject to risks and uncertainties and may be affected by various factors that may cause actual results to differ materially from those in the forward-looking statements. For further information that could cause actual results to differ from Cutera's expectations as well as other factors that could affect Cutera's financial statements, please refer to the Cutera's reports filed with the Securities and Exchange Commission. | 